Detalhe da pesquisa
1.
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.
FASEB J
; 36(10): e22514, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106439
2.
Glucosylceramide production maintains colon integrity in response to Bacteroides fragilis toxin-induced colon epithelial cell signaling.
FASEB J
; 34(12): 15922-15945, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33047400
3.
Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis.
J Virol
; 93(12)2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918081
4.
Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
J Transl Med
; 15(1): 149, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662726
5.
Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.
J Cell Mol Med
; 17(8): 1048-58, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23890189
6.
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Blood Rev
; 55: 100950, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487785
7.
Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis.
Life (Basel)
; 11(11)2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34833128
8.
Role of SPTSSB-Regulated de Novo Sphingolipid Synthesis in Prostate Cancer Depends on Androgen Receptor Signaling.
iScience
; 23(12): 101855, 2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313495
9.
Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma.
Mol Cancer Ther
; 19(12): 2621-2633, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087509
10.
Glucosylceramide synthase maintains influenza virus entry and infection.
PLoS One
; 15(2): e0228735, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032363
11.
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Adv Cancer Res
; 140: 327-366, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30060815
12.
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Clin Epigenetics
; 10(1): 132, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373654
13.
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Cell Death Dis
; 9(2): 167, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415999
14.
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Cancer Lett
; 385: 150-159, 2017 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984115
15.
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.
Epigenetics
; 12(12): 1057-1064, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29099276
16.
Prognostic significance of MST1R dysregulation in renal cell tumors.
Am J Cancer Res
; 6(8): 1799-811, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648366
17.
Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
J Biomed Nanotechnol
; 12(8): 1667-78, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342345
18.
Diagnostic and prognostic epigenetic biomarkers in cancer.
Epigenomics
; 7(6): 1003-15, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479312
19.
MicroRNA-375 plays a dual role in prostate carcinogenesis.
Clin Epigenetics
; 7: 42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977730
20.
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.
Oncotarget
; 6(15): 13644-57, 2015 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980436